Syneron Medical Ltd (ELOS.OQ)
26 May 2017
* Sand Grove Capital Management Llp reports 5.2 percent stake in Syneron Medical Ltd as of April 28 - SEC filing Source text - (http://bit.ly/2qZ8itX) Further company coverage:
TEL AVIV, April 3 British private equity firm Apax Partners has agreed to buy Israel's Syneron Medical Ltd, a non-surgical aesthetic device company, for $11.00 per share in cash, or a total of $397 million, the companies said on Monday.
* Syneron Candela announces agreement to be acquired by funds advised by Apax Partners for $11.00/share in cash, representing an approximate value of $397 million
JERUSALEM, April 2 British private equity fund Apax Partners is close to finalizing a deal to buy Israel-based Syneron Medical, an aesthetic device company, for about $500 million, Israeli media reported on Sunday.